Type
Business expansion
Country
Spain
Region
Este; Cataluña; Barcelona
Location of affected unit(s)
Barcelona
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture Of Basic Pharmaceutical Products

830 jobs
Number of planned job creations
Job creation
Announcement Date
28 February 2025
Employment effect (start)
3 March 2025
Foreseen end date

Description

The British-Swedish pharmaceutical company AstraZeneca is expecting to move its Global Hub to the Estel building in Barcelona by the end of 2025, resulting in the creation of 830 new Jobs by the end of 2025.

For this purpose, the company plans to invest up to EUR 1.3 billion euro in this R&D centre until 2027 and create a team of 2,000 workers by the end of 2025. The AstraZeneca Global Hub, spanning 25,000 square metres, is dedicated to accelerating the development of a new generation of treatments across key therapeutic areas: oncology, rare diseases, cardiovascular, renal and metabolic conditions, respiratory and immunology, as well as vaccines and immunotherapies.

The company experienced an internal restructuring process in 2008, affecting 132 employees Astra Zeneca 2008-ES


Sources

Citation

Eurofound (2025), Astra Zeneca Spain, Business expansion in Spain, factsheet number 202434, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/202434.